Display options
Cite
Wadman I, Li J, Bash RO, et al. Specific in vivo association between the bHLH and LIM proteins implicated in human T cell leukemia. EMBO J. 1994;13(20):4831-9
Wadman, I., Li, J., Bash, R. O., Forster, A., Osada, H., Rabbitts, T. H., & Baer, R. (1994). Specific in vivo association between the bHLH and LIM proteins implicated in human T cell leukemia. The EMBO journal, 13(20), 4831-9.
Wadman, I, et al. "Specific in vivo association between the bHLH and LIM proteins implicated in human T cell leukemia." The EMBO journal vol. 13,20 (1994): 4831-9.
Wadman I, Li J, Bash RO, Forster A, Osada H, Rabbitts TH, Baer R. Specific in vivo association between the bHLH and LIM proteins implicated in human T cell leukemia. EMBO J. 1994 Oct 17;13(20):4831-9. PMID: 7957052; PMCID: PMC395422.
Copy Download .nbib Format: NLM
Share it on
Full text links
Wiley Free PMC Article

EMBO J. 1994 Oct 17;13(20):4831-9.

Specific in vivo association between the bHLH and LIM proteins implicated in human T cell leukemia.

The EMBO journal

I Wadman, J Li, R O Bash, A Forster, H Osada, T H Rabbitts, R Baer

Affiliations

  1. Department of Microbiology, University of Texas Southwestern Medical Center, Dallas 75235.

PMID: 7957052 PMCID: PMC395422
Free PMC Article

Abstract

The protein products of proto-oncogenes implicated in T cell acute lymphoblastic leukemia include two distinct families of presumptive transcription factors. RBTN1 and RBTN2 encode highly related proteins that possess cysteine-rich LIM motifs. TAL1, TAL2 and LYL1 encode a unique subgroup of basic helix-loop-helix (bHLH) proteins that share exceptional homology in their bHLH sequences. We have found that RBTN1 and RBTN2 have the ability to interact with each of the leukemogenic bHLH proteins (TAL1, TAL2 and LYL1). These interactions occur in vivo and appear to be mediated by sequences within the LIM and bHLH domains. The LIM-bHLH interactions are highly specific in that RBTN1 and RBTN2 will associate with TAL1, TAL2 and LYL1, but not with other bHLH proteins, including E12, E47, Id1, NHLH1, AP4, MAX, MYC and MyoD1. Moreover, RBTN1 and RBTN2 can interact with TAL1 polypeptides that exist in assembled bHLH heterodimers (e.g. TAL1-E47), suggesting that the RBTN proteins can influence the functional properties of TAL1. Finally, we have identified a subset of leukemia patients that harbor tumor-specific rearrangements of both their RBTN2 and TAL1 genes. Thus, the activated alleles of these genes may promote leukemia cooperatively, perhaps as a result of bHLH-LIM interactions between their protein products.

Cited by

References

  1. Cell. 1991 Feb 8;64(3):521-32 - PubMed
  2. Genes Dev. 1992 Nov;6(11):2165-76 - PubMed
  3. Oncogene. 1992 Dec;7(12):2389-97 - PubMed
  4. J Cell Biol. 1992 Dec;119(6):1573-87 - PubMed
  5. Cell Growth Differ. 1993 Jan;4(1):49-55 - PubMed
  6. Blood. 1993 Feb 1;81(3):647-55 - PubMed
  7. Cell. 1993 Feb 12;72(3):309-24 - PubMed
  8. Proc Natl Acad Sci U S A. 1993 Feb 15;90(4):1580-4 - PubMed
  9. Oncogene. 1993 Mar;8(3):677-83 - PubMed
  10. Blood. 1993 Apr 15;81(8):2110-7 - PubMed
  11. Nature. 1993 May 6;363(6424):38-45 - PubMed
  12. Proc Natl Acad Sci U S A. 1993 May 15;90(10):4404-8 - PubMed
  13. Oncogene. 1993 Nov;8(11):3043-6 - PubMed
  14. EMBO J. 1993 Nov;12(11):4243-50 - PubMed
  15. Proc Natl Acad Sci U S A. 1994 Jan 4;91(1):316-20 - PubMed
  16. Genes Chromosomes Cancer. 1990 Jan;1(3):194-208 - PubMed
  17. Proc Natl Acad Sci U S A. 1986 Apr;83(8):2516-20 - PubMed
  18. EMBO J. 1988 Feb;7(2):385-94 - PubMed
  19. Cell. 1988 Jul 1;54(1):5-16 - PubMed
  20. Mol Cell Biol. 1988 May;8(5):2159-65 - PubMed
  21. Cell. 1989 Mar 10;56(5):777-83 - PubMed
  22. Proc Natl Acad Sci U S A. 1991 May 15;88(10):4367-71 - PubMed
  23. Mol Cell Biol. 1991 Jun;11(6):3037-42 - PubMed
  24. Biotechniques. 1991 Mar;10(3):330 - PubMed
  25. Oncogene. 1991 Aug;6(8):1477-88 - PubMed
  26. Oncogene. 1991 Oct;6(10):1887-93 - PubMed
  27. Cell. 1991 Nov 15;67(4):641-4 - PubMed
  28. Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9671-4 - PubMed
  29. EMBO J. 1991 Dec;10(13):4153-8 - PubMed
  30. Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11416-20 - PubMed
  31. Cell. 1992 Feb 7;68(3):507-19 - PubMed
  32. Blood. 1992 Mar 1;79(5):1327-33 - PubMed
  33. J Cell Biol. 1992 Mar;116(6):1381-93 - PubMed
  34. Oncogene. 1992 Apr;7(4):653-60 - PubMed
  35. Mol Cell Biol. 1992 Sep;12(9):4186-96 - PubMed
  36. Gene. 1992 Sep 1;118(1):137-41 - PubMed
  37. EMBO J. 1992 Nov;11(11):4073-81 - PubMed
  38. Biochemistry. 1994 Jan 18;33(2):468-77 - PubMed
  39. Mol Cell Biol. 1994 Feb;14(2):1256-65 - PubMed
  40. EMBO J. 1994 Jan 1;13(1):180-9 - PubMed
  41. Semin Cancer Biol. 1993 Dec;4(6):341-7 - PubMed
  42. Semin Cancer Biol. 1993 Dec;4(6):349-58 - PubMed
  43. Oncogene. 1994 May;9(5):1437-46 - PubMed
  44. Proc Natl Acad Sci U S A. 1994 Apr 12;91(8):3181-5 - PubMed
  45. Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):5947-51 - PubMed
  46. Cell. 1994 Jul 15;78(1):45-57 - PubMed
  47. Proc Natl Acad Sci U S A. 1994 Aug 30;91(18):8617-21 - PubMed
  48. Genes Dev. 1994 Apr 15;8(8):970-80 - PubMed
  49. J Biol Chem. 1989 May 15;264(14):8222-9 - PubMed
  50. Proc Natl Acad Sci U S A. 1989 Jul;86(13):5039-43 - PubMed
  51. Mol Cell Biol. 1989 May;9(5):2124-32 - PubMed
  52. Blood. 1989 Jul;74(1):374-9 - PubMed
  53. Cell. 1989 Jul 14;58(1):77-83 - PubMed
  54. Nature. 1989 Jul 20;340(6230):245-6 - PubMed
  55. Nucleic Acids Res. 1989 Sep 25;17(18):7539 - PubMed
  56. Proc Natl Acad Sci U S A. 1989 Dec;86(24):10128-32 - PubMed
  57. EMBO J. 1990 Feb;9(2):415-24 - PubMed
  58. J Exp Med. 1990 Feb 1;171(2):489-501 - PubMed
  59. Nature. 1990 Apr 26;344(6269):876-9 - PubMed
  60. Nature. 1990 Apr 26;344(6269):879-82 - PubMed
  61. Nucleic Acids Res. 1990 Jul 11;18(13):3871-9 - PubMed
  62. Nature. 1990 Aug 2;346(6283):418 - PubMed
  63. Blood. 1990 Sep 15;76(6):1220-4 - PubMed
  64. EMBO J. 1990 Oct;9(10):3343-51 - PubMed
  65. Mol Cell Biol. 1991 Feb;11(2):954-62 - PubMed

Substances

MeSH terms

Publication Types

Grant support

LinkOut - more resources